The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and re...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
_version_ | 1797089911877140480 |
---|---|
author | Altshuler, D Hirschhorn, J Klannemark, M Lindgren, C Vohl, M Nemesh, J Lane, C Schaffner, S Bolk, S Brewer, C Tuomi, T Gaudet, D Hudson, T Daly, M Groop, L Lander, E |
author_facet | Altshuler, D Hirschhorn, J Klannemark, M Lindgren, C Vohl, M Nemesh, J Lane, C Schaffner, S Bolk, S Brewer, C Tuomi, T Gaudet, D Hudson, T Daly, M Groop, L Lander, E |
author_sort | Altshuler, D |
collection | OXFORD |
description | Genetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and related sub-phenotypes using a family-based design to control for population stratification, and replication samples to increase power. We were able to confirm only one association, that of the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(PPARgamma) with type 2 diabetes. By analysing over 3,000 individuals, we found a modest (1.25-fold) but significant (P=0.002) increase in diabetes risk associated with the more common proline allele (85% frequency). Moreover, our results resolve a controversy about common variation in PPARgamma. An initial study found a threefold effect, but four of five subsequent publications failed to confirm the association. All six studies are consistent with the odds ratio we describe. The data implicate inherited variation in PPARgamma in the pathogenesis of type 2 diabetes. Because the risk allele occurs at such high frequency, its modest effect translates into a large population attributable risk-influencing as much as 25% of type 2 diabetes in the general population. |
first_indexed | 2024-03-07T03:10:51Z |
format | Journal article |
id | oxford-uuid:b425e044-35a3-46c2-80ae-48d92f24e65f |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T03:10:51Z |
publishDate | 2000 |
record_format | dspace |
spelling | oxford-uuid:b425e044-35a3-46c2-80ae-48d92f24e65f2022-03-27T04:24:05ZThe common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b425e044-35a3-46c2-80ae-48d92f24e65fEnglishSymplectic Elements at Oxford2000Altshuler, DHirschhorn, JKlannemark, MLindgren, CVohl, MNemesh, JLane, CSchaffner, SBolk, SBrewer, CTuomi, TGaudet, DHudson, TDaly, MGroop, LLander, EGenetic association studies are viewed as problematic and plagued by irreproducibility. Many associations have been reported for type 2 diabetes, but none have been confirmed in multiple samples and with comprehensive controls. We evaluated 16 published genetic associations to type 2 diabetes and related sub-phenotypes using a family-based design to control for population stratification, and replication samples to increase power. We were able to confirm only one association, that of the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-gamma(PPARgamma) with type 2 diabetes. By analysing over 3,000 individuals, we found a modest (1.25-fold) but significant (P=0.002) increase in diabetes risk associated with the more common proline allele (85% frequency). Moreover, our results resolve a controversy about common variation in PPARgamma. An initial study found a threefold effect, but four of five subsequent publications failed to confirm the association. All six studies are consistent with the odds ratio we describe. The data implicate inherited variation in PPARgamma in the pathogenesis of type 2 diabetes. Because the risk allele occurs at such high frequency, its modest effect translates into a large population attributable risk-influencing as much as 25% of type 2 diabetes in the general population. |
spellingShingle | Altshuler, D Hirschhorn, J Klannemark, M Lindgren, C Vohl, M Nemesh, J Lane, C Schaffner, S Bolk, S Brewer, C Tuomi, T Gaudet, D Hudson, T Daly, M Groop, L Lander, E The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title_full | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title_fullStr | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title_full_unstemmed | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title_short | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
title_sort | common ppargamma pro12ala polymorphism is associated with decreased risk of type 2 diabetes |
work_keys_str_mv | AT altshulerd thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT hirschhornj thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT klannemarkm thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT lindgrenc thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT vohlm thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT nemeshj thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT lanec thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT schaffners thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT bolks thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT brewerc thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT tuomit thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT gaudetd thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT hudsont thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT dalym thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT groopl thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT landere thecommonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT altshulerd commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT hirschhornj commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT klannemarkm commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT lindgrenc commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT vohlm commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT nemeshj commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT lanec commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT schaffners commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT bolks commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT brewerc commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT tuomit commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT gaudetd commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT hudsont commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT dalym commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT groopl commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes AT landere commonppargammapro12alapolymorphismisassociatedwithdecreasedriskoftype2diabetes |